Replies to post #14733 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Correction, Easka I misread the earnout as being for 2023, it is to be paid out in 2024, though it was earned in Q4 of 2023. So we are probably looking at net income north of $7 million. Hard to say what revenue will but will likely be i figure it should be north of $128 million.

Stock Analysis have 6 analyst pegging revenue for the year at $486.09 million, $8 million above ANIP's top guidance of $478 million.